142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

315211
Implementation and integration of a naloxone-based opioid overdose response protocol in organizations serving opioid users: A qualitative study

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

R. Mitchell Thomas, MSW , Center for Addictions Research and Services, Boston University School of Social Work, Boston, MA
Meredith Munn, BA, MSW , Social and Behavioral Sciences, Boston University School of Public Health, Boston, MA
Carolyn Reckhow, BA , Boston University School of Public Health, Boston, MA
Deborah Chassler, MSW , Center for Addictions Research and Services, Boston University School of Social Work, Boston, MA
Timothy Purington, M.Ed. , Tapestry Health, Inc., Springfield, MA
Alexander Walley, MD, MSc , Department of Medicine, Boston University School of Medicine, Boston, MA
Lena Lundgren, PhD , Center for Addictions Research and Services, Boston University School of Social Work, Boston, MA
Purpose:

Instances of opioid overdoses are increasing across the country. As an evidence-based practice (EBP), Naloxone, an opioid antagonist, has been proven effective in reversing overdoses when administered intra-nasally. Utilizing Simpson and Flynn’s Organizational Readiness for Change (TCU-ORC) model, this study explores the decision-making processes guiding the implementation and integration of a naloxone-based opioid overdose response protocol (NBOORP) in organizations providing services to heroin and other opioid users in Western Massachusetts.

Methods:

Qualitative interviews were conducted with 75 program directors and staff from organizations which received naloxone responder training. Participants were asked (1) to describe the decision-making process that led to the implementation of their NBOORP, (2) how, if at all, the NBOORP was integrated into the organization’s service model, and, (3) if integrated, whether a NBOORP was currently and routinely used to reverse overdoses.  Participants completed a modified version of the TCU-ORC measures focusing on program needs, workplace stress, and staff’s perceived organizational influence.

Results:

Preliminary analysis shows a significant barrier to implementation is administrative concerns around organizational liability, especially in for-profit organizations. Most organizations implemented a NBOORP immediately after training and prior to developing a written policy. Additionally, the quantitative measures will assess the impact of perceived barriers and the organization’s readiness for change on its ability to implement a NBOORP.

Discussion:

The identification of characteristics linked to the successful implementation of a NBOORP will increase understanding of a model for rapid infusion of an EBP, Naloxone, for service providers offering a range of services to opioid users.

Learning Areas:

Administer health education strategies, interventions and programs
Implementation of health education strategies, interventions and programs

Learning Objectives:
Identify organizational characteristics which facilitate the rapid implementation of a naloxone-based opioid overdose response protocol Describe perceived barriers by staff that impede the implementation and/or integration of a naloxone-based opioid overdose response protocol into organizational standard operating procedures Evaluate the impact of program needs, workplace stress, and staff’s perceived level of influence

Keyword(s): Drug Abuse Prevention and Safety

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have participated in and presented research regarding the implementation of evidence based interventions in substance abuse settings. I also have experience working with organizations to get their staff trained to distribute Narcan and currently work with a syringe access program which trains staff at organizations where people are likely to overdose on opioids to administer Narcan in the event of an overdose.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.